Sagefield Capital »

Apellis Pharmaceuticals shares owned by Sagefield Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Sagefield Capital from 13F filings

Historical chart of Sagefield Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Sagefield Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Sagefield Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 104k 40.23

More positions owned by Sagefield Capital

Chesapeake Energy Corp (EXE)
Permian Resources Corp Class A Com (PR)
Matador Resources (MTDR)
Technipfmc (FTI)
ConocoPhillips (COP)
Digitalbridge Group Cl A New (DBRG)
Webster Financial Corporation (WBS)
Seadrill 2021 (SDRL)
Apa Corporation (APA)
Cabot Oil & Gas Corporation (CTRA)
Valero Energy Corporation (VLO)
Range Resources (RRC)
Exxon Mobil Corporation (XOM)
Encana Corporation (OVV)
Tri Pointe Homes (TPH)

View all positions for Sagefield Capital

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals